Spruce Biosciences Inc — Liquidità Trimestrale (NASDAQ:SPRB) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 45.21 M31.65 M21.82 M15.31 M53.02 M Totale passività 16.39 M16.32 M8.64 M9.93 M10.51 M Patrimonio netto totale 28.82 M15.32 M13.18 M5.39 M42.52 M Totale passività e patrimonio netto 45.21 M31.65 M21.82 M15.31 M53.02 M Debito totale 1.75 M1.34 M943 K539 K0 Indebitamento netto -37.05 M-24.25 M-15.46 M-10.16 M-48.9 M

Notizie

Citizens conferma il rating su Spruce Biosciences in vista dell’approvazione

Spruce Biosciences pone fine all’accordo di collaborazione con Kaken Pharmaceutical

Spruce Biosciences nomina Dale Hooks chief commercial officer

Spruce Biosciences names Dale Hooks as chief commercial officer

3 ‘Strong Buy’ Stocks to Buy Now, 2/6/2026, According to Top Analysts - TipRanks.com

Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences - Spruce Biosciences (NASDAQ:SPRB)

Biotech Stocks' Dark Winter Is Over. What That Means For Investors.

Oppenheimer avvia copertura su Spruce Biosciences con rating Outperform

Oppenheimer initiates coverage on Spruce Biosciences stock with Outperform rating

This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Brunswick (NYSE:BC), Cellectis (NASDAQ:CLLS)

H.C. Wainwright riprende la copertura di Spruce Biosciences con rating Buy

Spruce Biosciences stock rating resumed at Buy by H.C. Wainwright